We are live on ! Find out more
JNJ icon

Johnson & Johnson

3,672 hedge funds and large institutions have $321B invested in Johnson & Johnson in 2022 Q2 according to their latest regulatory filings, with 131 funds opening new positions, 1,619 increasing their positions, 1,536 reducing their positions, and 88 closing their positions.

New
Increased
Maintained
Reduced
Closed

49% more first-time investments, than exits

New positions opened: 131 | Existing positions closed: 88

45% more funds holding in top 10

Funds holding in top 10: 532773 (+241)

33% more call options, than puts

Call options by funds: $3.35B | Put options by funds: $2.52B

5% more repeat investments, than reductions

Existing positions increased: 1,619 | Existing positions reduced: 1,536

0.04% less ownership

Funds ownership: 69.15%69.11% (-0.04%)

0% less funds holding

Funds holding: 3,6773,672 (-5)

12% less capital invested

Capital invested by funds: $365B → $321B (-$44.1B)

Holders
3,672
Holders Change
-5
Holders Change %
-0.14%
% of All Funds
61.85%
Holding in Top 10
773
Holding in Top 10 Change
+241
Holding in Top 10 Change %
+45.3%
% of All Funds
13.02%
New
131
Increased
1,619
Reduced
1,536
Closed
88
Calls
$3.35B
Puts
$2.52B
Net Calls
+$833M
Net Calls Change
-$135M
Name Holding Trade Value Shares
Change
Change in
Stake
PWLP
326
Prio Wealth Limited Partnership
Massachusetts
$56.6M +$116K +653 +0.2%
CFB
327
Cullen/Frost Bankers
Texas
$56.3M +$1.49M +8,371 +3%
KAS
328
Kestra Advisory Services
Texas
$55.6M +$7.64M +42,875 +16%
SMDAM
329
Sumitomo Mitsui DS Asset Management
Japan
$54.9M +$4.52M +25,354 +9%
NSLI
330
Nan Shan Life Insurance
Taiwan
$54.8M
OSAM
331
O'Shaughnessy Asset Management
Connecticut
$54.5M +$4.93M +27,659 +10%
CDH
332
Charles D. Hyman
$54.5M +$175K +980 +0.3%
BCIM
333
British Columbia Investment Management
British Columbia, Canada
$54.2M -$18.1M -101,505 -25%
SBH
334
Segall Bryant & Hamill
Illinois
$53.9M -$1.16M -6,503 -2%
UH
335
Unigestion Holding
Switzerland
$53M +$2.15M +12,060 +4%
MAM
336
Madison Asset Management
Wisconsin
$52.7M +$9.75M +54,737 +23%
OC
337
Oppenheimer & Co
New York
$52.5M -$183K -1,025 -0.3%
CCM
338
Compass Capital Management
Minnesota
$52.4M -$5.07M -28,459 -9%
SF
339
Synovus Financial
Georgia
$52.4M +$2.19M +12,312 +4%
ACM
340
Advisors Capital Management
New Jersey
$52.3M +$1.74M +9,741 +3%
BMO
341
Beck Mack & Oliver
New York
$51.8M -$378K -2,121 -0.7%
BHC
342
Bowen Hanes & Co
Florida
$51.8M +$2.32M +13,048 +5%
FWCM
343
Ferguson Wellman Capital Management
Oregon
$51.7M +$116K +653 +0.2%
TAF
344
Tredje AP-fonden
Sweden
$51.5M
VDI
345
Vaughan David Investments
Illinois
$51.5M +$86.9K +488 +0.2%
TAM
346
Troy Asset Management
United Kingdom
$51.3M +$7.63M +42,832 +17%
NC
347
Nicholas Company
Wisconsin
$51.3M -$8.62M -48,400 -14%
CIA
348
Capital Investment Advisors
Georgia
$51.2M +$1.33M +7,439 +3%
RMDI
349
R.M. Davis Inc
Maine
$51.1M -$413K -2,316 -0.8%
DILIC
350
Dai-ichi Life Insurance Company
Japan
$50.9M -$14.6M -81,954 -22%

JNJ Hedge Fund Activity: Q2 2022 in Review

3,672 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2022, worth a combined $321B — down 12% from $365B a quarter earlier.

Buyers outnumbered sellers: 131 funds opened new JNJ positions and 88 closed out — a net gain of 43 holders — while 1,619 added to existing stakes and 1,536 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $2.12B. The largest seller was Arrowstreet Capital, cutting an estimated $1.18B.

  • 3,672 institutional investors held Johnson & Johnson (JNJ) as of Q2 2022, down from 3,677 in Q1 2022.
  • Funds reported $321B of Johnson & Johnson stock for Q2 2022, down 12% quarter-over-quarter.
  • 131 funds opened new Johnson & Johnson positions in Q2 2022 and 88 closed out, a net change of +43 holders.
  • The largest Johnson & Johnson buyer in Q2 2022 was Morgan Stanley, an estimated $2.12B added.
  • The largest Johnson & Johnson seller in Q2 2022 was Arrowstreet Capital, an estimated $1.18B sold.

Based on aggregated 13F filings for Q2 2022.